Comparative assessment of the anxiety level with the immune response in the immunized population against coronavirus infection

Abstract

Introduction: Immunization of the vast majority of the world’s population is a way to prevent and reduce the risk of coronavirus infection. The purpose of this study is to compare with the basic and pre- & post-immunization anxieties of the subjects, vaccinated at doses 1 and 2 of the vaccine against coronavirus infection with post-immunization responses. Materials and Methods: The study design was descriptive and cross-sectional and data were collected using a semi-structured questionnaire. Results: 468 respondents aged 18-65 participated in the survey. The majority of them were female (n=272; 63.6%), and the sex ratio was 1.8:1. Of the total respondents, 68.9% (n=295) had a high level of basic anxiety. The current anxiety was detected in 76.6% of respondents before the first dose, and 46.5% before the second dose. 65% of the respondents had 24 symptoms of the immune response after the first dose (average of 4 symptoms per person), and after the second dose, these symptoms were determined to 51% of respondents (average of 2 symptoms per person). 9 of the symptoms of the immune response were occurred significantly related to basic anxiety. Conclusion: Among the population received two doses of immunization, 68.9% had a high level of basic anxiety, and some of the immune response symptoms were statistically significantly related to basic anxiety (p≤0.03)